PMID- 19496189 OWN - NLM STAT- MEDLINE DCOM- 20090817 LR - 20211020 IS - 2219-2840 (Electronic) IS - 1007-9327 (Print) IS - 1007-9327 (Linking) VI - 15 IP - 21 DP - 2009 Jun 7 TI - Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice. PG - 2602-8 AB - AIM: To explore the effect of silencing of signal transducer and activator of transcription 3 (STAT3) expression by RNA interference (RNAi) on growth of human hepatocellular carcinoma (HCC) in tumor-bearing nude mice in vivo. METHODS: To construct the recombinant plasmid of pSilencer 3.0-H1-STAT3-siRNA-GFP (pSH1-siRNA-STAT3) and establish the tumor-bearing nude mouse model of the HCC cell line SMMC7721, we used intratumoral injection together with electroblotting to transfect the recombinant plasmid pSH1-siRNA-STAT3 into the transplanted tumor. The weight of the nude mice and tumor volumes were recorded. STAT3 gene transcription was detected by semi-quantitative reverse transcription polymerase chain reaction (RT-PCR). Level of protein expression and location of STAT3 were determined by Western blotting and immunohistochemical staining. STAT3-related genes such as survivin, c-myc, VEGF, p53 and caspase3 mRNA and protein expression were detected in tumor tissues at the same time. The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay was used to detect apoptosis of tumor cells. RESULTS: The weight of the treated nude mice increased, and the tumor volume decreased markedly compared with those of the mock-treated and negative control groups (P < 0.01). The results of RT-PCR and Western blotting showed that mRNA and protein levels of STAT3 declined markedly in the treated group. The change in STAT3-related gene expression in tumor tissues at the mRNA and protein level also varied, the expression of survivin, VEGF and c-myc were obviously reduced, and expression of p53 and caspase3 increased (P < 0.01). Most of the tumor tissue cells in the treated group developed apoptosis that was detected by TUNEL assay. CONCLUSION: Silencing of STAT3 expression by RNAi significantly inhibits expression of STAT3 mRNA and protein, and suppresses growth of human HCC in tumor-bearing nude mice. The mechanism may be related to down-regulation of survivin, VEGF and c-myc and up-regulation of p53 and caspase3 expression. Accordingly, the STAT3 gene may act as an important and effective target in gene therapy of HCC. FAU - Li, Jing AU - Li J AD - Department of Gastroenterology, the First Hospital of Jilin University, 71 Xinmin Avenue, Changchun 130021, Jilin Province, China. FAU - Piao, Yun-Feng AU - Piao YF FAU - Jiang, Zheng AU - Jiang Z FAU - Chen, Li AU - Chen L FAU - Sun, Hai-Bo AU - Sun HB LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - World J Gastroenterol JT - World journal of gastroenterology JID - 100883448 RN - 0 (Birc5 protein, mouse) RN - 0 (Inhibitor of Apoptosis Proteins) RN - 0 (Microtubule-Associated Proteins) RN - 0 (Proto-Oncogene Proteins c-myc) RN - 0 (Repressor Proteins) RN - 0 (STAT3 Transcription Factor) RN - 0 (Stat3 protein, mouse) RN - 0 (Survivin) RN - 0 (Tumor Suppressor Protein p53) RN - 0 (Vascular Endothelial Growth Factor A) RN - EC 3.4.22.- (Caspase 3) SB - IM MH - Animals MH - *Carcinoma, Hepatocellular/genetics/metabolism/pathology MH - Caspase 3/genetics/metabolism MH - Cell Line, Tumor MH - Gene Expression Regulation, Neoplastic MH - *Gene Silencing MH - Humans MH - Inhibitor of Apoptosis Proteins MH - *Liver Neoplasms/genetics/metabolism/pathology MH - Male MH - Mice MH - Mice, Inbred BALB C MH - *Mice, Nude MH - Microtubule-Associated Proteins/genetics/metabolism MH - Neoplasm Transplantation MH - Proto-Oncogene Proteins c-myc/genetics/metabolism MH - RNA Interference MH - Repressor Proteins MH - *STAT3 Transcription Factor/genetics/metabolism MH - Survivin MH - Tumor Suppressor Protein p53/genetics/metabolism MH - Vascular Endothelial Growth Factor A/genetics/metabolism PMC - PMC2691490 EDAT- 2009/06/06 09:00 MHDA- 2009/08/18 09:00 PMCR- 2009/06/07 CRDT- 2009/06/05 09:00 PHST- 2009/06/05 09:00 [entrez] PHST- 2009/06/06 09:00 [pubmed] PHST- 2009/08/18 09:00 [medline] PHST- 2009/06/07 00:00 [pmc-release] AID - 10.3748/wjg.15.2602 [doi] PST - ppublish SO - World J Gastroenterol. 2009 Jun 7;15(21):2602-8. doi: 10.3748/wjg.15.2602.